Cargando…

Osteoclasts are essential for TNF-mediated joint destruction

Detalles Bibliográficos
Autores principales:	Redlich, KR, Hayer, S, Ricci, R, David, JP, Tohidast-Akrad, M, Zwerina, J, Kollias, G, Steiner, G, Smolen, JS, Wagner, E, Schett, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2002
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273096/ http://dx.doi.org/10.1186/ar434

Ejemplares similares

Therapeutic targeting of osteoclasts by osteoprotegerin and bisphosphonates leads to a reduction of TNFalpha-mediated bone resorption
por: Redlich, K, et al.
Publicado: (2001)

Adenoviral-based overexpression of TIMP-1 reduces tissue damage in the joints TNF-transgenic mice
por: Schett, G, et al.
Publicado: (2001)

Effect of osteoprotegerin and pamidronate treatment in transgenic mice overexpressing human TNF
por: Redlich, K, et al.
Publicado: (2001)

Adenoviral-based overexpression of TIMP-1 reduces tissue damage in the joints of TNF-alpha transgenic mice
por: Schett, G, et al.
Publicado: (2001)

Aberrant expression of the autoantigen hnRNP-A2/RA33 in the joints of patients with rheumatoid arthritis and TNF-alpha transgenic mice: a clue to autoimmunity?
por: Hayer, S, et al.
Publicado: (2001)

Overexpression of TNF causes bilateral sacroiliitis
por: Redlich, K, et al.
Publicado: (2004)

Isolated and combined inhibition of TNF-, IL-1 and RANKL-pathways in TNF-induced arthritis: effects on synovial inflammation, bone erosion and cartilage destruction
por: Zwerina, J, et al.
Publicado: (2003)

Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-TNF in combination with OPG or PTH in TNF-mediated arthritis
por: Redlich, K, et al.
Publicado: (2004)

Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation
por: Görtz, B, et al.
Publicado: (2004)

Overexpression of the autoantigen hnRNP-A2 (RA33), the tumour suppressor p53 and activated MAP-Kinase p38 in inflamed synovial tissue
por: Hayer, S, et al.
Publicado: (2002)

Osteoprotegerin protects from generalized bone loss in TNF-transgenic mice
por: Hayer, S, et al.
Publicado: (2003)

Zoledronic acid protects from local and systemic bone loss in TNF-mediated arthritis
por: Zwerina, J, et al.
Publicado: (2004)

CD44 regulates bone erosion and osteoclastogenesis in arthritis
por: Hayer, S, et al.
Publicado: (2004)

JNK1 is not essential for TNF-mediated joint disease
por: Köller, Marcus, et al.
Publicado: (2005)

Autoantibodies to hnRNP-A2 in SLE: identification of disease-specific linear epitopes and correlation with disease activity and clinical features
por: Schett, G, et al.
Publicado: (2003)

CD44 regulates bone erosion and osteoclastogenesis in arthritis
por: Schett, G, et al.
Publicado: (2003)

CD44 is a determinant of inflammatory bone loss
por: Hayer, Silvia, et al.
Publicado: (2005)

The stressed synovium
por: Schett, Georg, et al.
Publicado: (2001)

Identification of hnRNP-A2 (RA33) as a major B-cell and T-cell autoantigen in pristane–induced arthritis
por: Hoffmann, MH, et al.
Publicado: (2005)

Heme oxygenase 1 regulates osteoclastogenesis
por: Zwerina, J, et al.
Publicado: (2005)

Tumor necrosis factor alpha downregulates bone morphogenetic protein expression and matrix macromolecule synthesis in articular cartilage
por: Bobacz, K, et al.
Publicado: (2004)

Characterization of the T cell response to hnRNP-A2 (RA33) in HLA-DR4 transgenic mice
por: Hoffmann, M, et al.
Publicado: (2004)

Zoledronic acid protects from local and systemic bone loss in tumor necrosis factor-mediated arthritis
por: Redlich, K, et al.
Publicado: (2004)

Comparative analysis of anti-histone and anti-chromatin antibody specificity in lupus erythematosus cell-positive and -negative sera and their relation to disease activity
por: Schett, G, et al.
Publicado: (2001)

Autoantibodies to the TNF-α translational regulators TIA-1 and TIAR occur frequently in sera of patients with SLE and scleroderma
por: Jimenez-Boj, E, et al.
Publicado: (2002)

Repair of local bone erosions by combined treatment with parathyroid hormone, osteoprotegerin and anti-tumor necrosis factor in tumor necrosis factor-transgenic mice
por: Redlich, K, et al.
Publicado: (2003)

Fra-1 regulates inflammatory and degenerative arthritis
por: Kireva, T, et al.
Publicado: (2010)

Tumour necrosis factor activates the mitogen-activated protein kinases p38α and ERK in the synovial membrane in vivo
por: Görtz, Birgit, et al.
Publicado: (2005)

Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis
por: Zwerina, Jochen, et al.
Publicado: (2006)

Clinical and immunological effects of anti-TNF therapy in systemic lupus erythematosus (SLE)
por: Aringer, M, et al.
Publicado: (2003)

Direct analysis of bone turnover in experimental arthritis
por: Polzer, K, et al.
Publicado: (2005)

Combined depletion of interleukin-1 and interleukin-6 does not exceed single depletion of interleukin -1 in TNF-mediated arthritis
por: Hayer, Silvia, et al.
Publicado: (2012)

Analysis of anti-Ro52 antibodies in sera of healthy subjects
por: Zimmermann, C, et al.
Publicado: (2001)

Tumour necrosis factor-dependent inflammatory cartilage destruction
por: Korb, A, et al.
Publicado: (2007)

Interphase fluorescence in situ hybridization analysis of fibroblast-like synoviocytes of patients with rheumatoid arthritis and osteoarthritis
por: Kiener, HP, et al.
Publicado: (2001)

T lymphocytes of patients with SLE lack Stat4
por: Aringer, M, et al.
Publicado: (2001)

Autoantibodies to the mRNA destabilizing protein hnRNP-D/AUF1 in patients with systemic autoimmune diseases
por: Skriner, K, et al.
Publicado: (2001)

Inhibition of Syndecan-4 by therapeutic antibodies reduces TNFα dependent joint destruction in mice
por: Stratis, Athanasios, et al.
Publicado: (2012)

Diabetes-induced osteoarthritis: role of hyperglycemia in joint destruction
por: Mendes, Alexandrina F, et al.
Publicado: (2015)

A polymorphism in the IL-10 promoter affects autoantibody production and subsequent joint destruction in rheumatoid arthritis
por: van Gaalen, FA, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_2n8sd0se8k1uo2rpcoedu5lfkg